Jon O Ebbert Selected Research

Tobacco Use Disorder (Nicotine Dependence)

1/2018	Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.
8/2017	Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.
3/2016	Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users.
1/2016	The safety of treatments for tobacco use disorder.
1/2016	Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence.
12/2015	A Critical Review of Repurposing Apomorphine for Smoking Cessation.
6/2014	Emerging drugs for the treatment of tobacco dependence: 2014 update.
1/2014	Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
1/2014	Larval zebrafish model for FDA-approved drug repositioning for tobacco dependence treatment.
7/2012	Tobacco dependence counseling in a randomized multisite clinical trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jon O Ebbert Research Topics

Disease

31	Tobacco Use Disorder (Nicotine Dependence) 01/2018 - 08/2002
10	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2012 - 08/2002
8	Weight Gain 01/2019 - 08/2002
7	Pain (Aches) 10/2019 - 11/2012
5	Overweight 04/2020 - 01/2014
5	Obesity 03/2020 - 02/2013
4	Nausea 10/2016 - 07/2007
3	Substance-Related Disorders (Drug Abuse) 10/2019 - 03/2005
3	Seizures (Absence Seizure) 01/2016 - 01/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 01/2009
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2015 - 07/2005
2	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 10/2019
2	Weight Loss (Weight Reduction) 04/2020 - 01/2016
2	Body Weight (Weight, Body) 04/2020 - 01/2016
2	Neoplasms (Cancer) 01/2019 - 06/2007
2	Alcoholism (Alcohol Abuse) 01/2018 - 01/2011
2	Mental Disorders (Mental Disorder) 01/2016 - 01/2009
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2015 - 09/2007
2	Coronary Disease (Coronary Heart Disease) 11/2012 - 06/2007
2	Lung Neoplasms (Lung Cancer) 04/2006 - 07/2005
1	Opiate Overdose 01/2022
1	Pelvic Pain 01/2021
1	Inflammation (Inflammations) 03/2020
1	Insulin Resistance 03/2020
1	Atherosclerosis 03/2020
1	Atherosclerotic Plaque (Atheroma) 03/2020
1	Stroke (Strokes) 03/2020
1	Intractable Pain 01/2019
1	Migraine Disorders (Migraine) 01/2019
1	Low Back Pain (Lumbago) 11/2018
1	Obstructive Sleep Apnea 11/2018
1	Headache (Headaches) 01/2018
1	Chronic Pain 01/2018
1	Cancer Pain 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Breast Diseases (Breast Disease) 01/2016
1	Kidney Diseases (Kidney Disease) 01/2016
1	Hypersensitivity (Allergy) 01/2016
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2016
1	Erectile Dysfunction 12/2015
1	Parkinson Disease (Parkinson's Disease) 12/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Diabetes Mellitus 01/2015
1	Hyperinsulinism (Hyperinsulinemia) 02/2013
1	Hypertriglyceridemia 02/2013
1	Dyslipidemias (Dyslipidemia) 02/2013
1	Myocardial Infarction 11/2012
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2012

Drug/Important Bio-Agent (IBA)

15	Varenicline (Chantix)FDA Link 01/2018 - 04/2008
13	Nicotine FDA Link 12/2015 - 08/2002
11	Bupropion (Wellbutrin)FDA LinkGeneric 01/2016 - 08/2002
7	Opioid Analgesics (Opioids)IBA 10/2019 - 01/2017
6	Pharmaceutical PreparationsIBA 01/2016 - 04/2006
4	SmokeIBA 01/2015 - 07/2005
3	lorcaserinIBA 01/2018 - 01/2016
2	EndocannabinoidsIBA 01/2021 - 03/2020
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021 - 03/2020
2	Medical MarijuanaIBA 01/2019 - 11/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 06/2007
2	Tobacco Smoke Pollution (Passive Smoking)IBA 11/2012 - 09/2007
2	Dopamine (Intropin)FDA LinkGeneric 04/2008 - 01/2003
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 03/2020
1	anandamide (arachidonylethanolamide)IBA 03/2020
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2019
1	Tryptamines (Triptans)IBA 01/2019
1	Controlled SubstancesIBA 10/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	Serotonin (5 Hydroxytryptamine)IBA 01/2018
1	MMEIBA 01/2017
1	Apomorphine FDA Link 12/2015
1	Dopamine Agonists (Dopamine Agonist)IBA 12/2015
1	Hemoglobins (Hemoglobin)IBA 01/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2015
1	LDL CholesterolIBA 01/2015
1	Complement System Proteins (Complement)IBA 01/2014
1	Topiramate (Topamax)FDA LinkGeneric 01/2014
1	Phentermine (Adipex-P)FDA LinkGeneric 01/2014
1	HDL CholesterolIBA 02/2013
1	Insulin (Novolin)FDA Link 02/2013
1	Glucose (Dextrose)FDA LinkGeneric 02/2013
1	Nonesterified Fatty Acids (NEFA)IBA 02/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2013
1	Triglycerides (Triacylglycerol)IBA 02/2013
1	CarbohydratesIBA 02/2013
1	HDL LipoproteinsIBA 02/2013
1	Biomarkers (Surrogate Marker)IBA 11/2012

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2016 - 05/2005
9	Therapeutics 10/2018 - 01/2003
8	Tobacco Use Cessation Devices 03/2016 - 09/2002
5	Nicotine Replacement Therapy 01/2016 - 01/2005
2	Low-Level Light Therapy (LLLT) 04/2020 - 01/2016
1	Immunomodulation 03/2020
1	Bibliotherapy 01/2019
1	Injections 01/2019
1	Contraindications 01/2016
1	Chemoprevention 01/2016
1	Caloric Restriction 01/2014